As the upstream activator of the JAK2/STAT3 pathway, the increased expression of IL-6 and the activation of JAK2/STAT3 signaling pathway have an impact on the prognosis of patients with NPC, shortening the survival time and providing potential targets for the treatment of NPC.6 Here, IL6 is linked to nasopharyngeal carcinoma.